This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Synthesis and spectral properties of estrogen- and androgen-BODIPY conjugates.
Steroids · 2017
BODIPY-17α-ethynylestradiol conjugates: Synthesis, fluorescence properties and receptor binding affinities.
Bioorganic & medicinal chemistry letters · 2017
Latest funding
- $1,086,300
Novel treatment of Alzheimer's disease by early targeting and visualizing soluble amyloid beta oligomers using cyclic azapeptides
CIHR · 2025 · Nominated PI
- $1,032,750
Brain-Penetrating Apelin Receptor Radioligands for Glioblastoma Therapy
CIHR · 2025 · Co-investigator
- $463,000
Cross-disciplinary Acuity Training Program in Intelligent and Responsible Drug Discovery
NSERC · 2023 · Co-investigator
2 publications.
Synthesis and spectral properties of estrogen- and androgen-BODIPY conjugates.
Osati S, Ali H, Guerin B, van Lier JE
BODIPY-17α-ethynylestradiol conjugates: Synthesis, fluorescence properties and receptor binding affinities.
Osati S, Ali H, Marques F, Paquette M, Beaudoin S, Guerin B, Leyton JV, van Lier JE
Novel treatment of Alzheimer's disease by early targeting and visualizing soluble amyloid beta oligomers using cyclic azapeptides
Principal investigators: Guérin, Brigitte; Lubell, William D; Rahimipour, Shai
Keywords: 64cu-Radiolabeled Conjugates; Abeta-Oligomers; Alzheimer'S Disease (Ad); Anti-Aggregation Activity; Azacyclopeptides; Cognitive Behavioral Studies; Early Diagnosis; Non-Fibrillar Aggregates; Pet-Ct-Mr Imaging; Treatment
Brain-Penetrating Apelin Receptor Radioligands for Glioblastoma Therapy
Principal investigators: Sarret, Philippe
Keywords: Apelin Ligands; Apelin Recptor; Blood-Brain Barrier; Glioblastoma; Pet Imaging; Radiotherapy
Cross-disciplinary Acuity Training Program in Intelligent and Responsible Drug Discovery
Principal investigators: SARRET, Philippe P
Keywords: advanced device technologies; artificial intelligence; biological targets; biosensors; computing science; drug discovery; imaging; medicinal chemistry
Rare Isotopes to Transform Cancer Therapy
Principal investigators: Bénard, François
Keywords: Radiopharmaceuticals; Targeted Radionuclide Therapy; Targeted Alpha Therapy; Cancer; Therapeutics; Nuclear Medicine; Radiology; Radiometals; Theranostic; Radioisotope
Imaging the contribution of early cerebrovascular inflammation in Alzheimer's disease
Principal investigators: Lepage, Martin
Keywords: Alzheimer'S Disease; Cerebrovascular Inflammation; Imaging Biomarker; Magnetic Resonance Imaging; Positron Emission Tomography
Conception et réalisation d'une unité de synthèse automatisée pour la préparation du [18F]-FMPEP-d2.
Principal investigators: Guérin, Brigitte
Tools for the preparation of peptide-based radioligands
Principal investigators: Guérin, Brigitte
High affinity inhibitors of PACE4 with therapeutic implications for prostate cancer
Principal investigators: Day, Robert
Keywords: C23; Cancer Animal Models; Drug Delivery; Enzyme Inhibitor; Imaging; Medicinal Chemistry; Pace4; Prodrugs; Structure Activity; Theranostics
Imaging, understanding, and managing radiotherapy inflammation and radiation necrosis
Principal investigators: Lepage, Martin
Keywords: Animal Imaging; Cancer; Imaging; Inflammation; Magnetic Resonance Imaging; Multimodality Imaging; Positron Emission Tomography; Pre-Clinical Model; Radiation Necrosis; Radiotherapy
A parallel evaporator for peptides, peptidomimetics and macrocycles
Principal investigators: Marsault, Eric
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.